FDA Approved: APRACLONIDINE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for apraclonidine filed by Sandoz Inc to modify/expand the drug's labeling or use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Apraclonidine (Apraclonidine)

Snippet

SUPPL AP for APRACLONIDINE (APRACLONIDINE)